Ionis Pharmaceuticals, Inc. (IONS)

Ionis Pharmaceuticals Stock Forecast

Stock Price Forecast

The 16 analysts with 12-month price forecasts for Ionis Pharmaceuticals stock have an average target of 57, with a low estimate of 37 and a high estimate of 77. The average target predicts an increase of 101.27% from the current stock price of 28.32.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$37	$57	$60	$77
Change	+30.65%	+101.27%	+111.86%	+171.89%

Analyst Ratings

The average analyst rating for Ionis Pharmaceuticals stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	5	5	5	6	6	7
Buy	7	7	7	7	6	4
Hold	5	5	5	5	6	6
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	18	18	18	19	19	18

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Stringer Needham	Needham	Strong Buy Reiterates $60	Strong Buy	Reiterates	$60	+111.86%	Apr 15, 2025
Joseph Stringer Needham	Needham	Strong Buy Reiterates $60	Strong Buy	Reiterates	$60	+111.86%	Apr 8, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $45	Strong Buy	Initiates	$45	+58.90%	Apr 7, 2025
Debjit Chattopadhyay Guggenheim	Guggenheim	Strong Buy Reiterates n/a	Strong Buy	Reiterates	n/a	n/a	Apr 3, 2025
Joshua Smith Redburn Atlantic	Redburn Atlantic	Hold Initiates $39	Hold	Initiates	$39	+37.71%	Mar 31, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

680.36M

Decreased by -3.51%

from 705.14M

Revenue Next Year

855.90M

Increased by 25.80%

from 680.36M

EPS This Year

-3.87

from -3.04

EPS Next Year

-3.12

from -3.87

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	729.26M	810.46M	587.37M	787.65M	705.14M	680.36M	855.90M	1.16B
Revenue Growth	-35.04%	11.13%	-27.53%	34.10%	-10.48%	-3.51%	25.80%	35.53%
EPS	-3.18	-0.20	-1.90	-2.56	-3.04	-3.87	-3.12	-1.72
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	27	23	17

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	841.1M	1.1B	1.7B
Avg	680.4M	855.9M	1.2B
Low	585.3M	661.6M	395.9M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	19.3%	63.1%	97.6%
Avg	-3.5%	25.8%	35.5%
Low	-17.0%	-2.8%	-53.7%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-2.93	-1.83	-0.63
Avg	-3.87	-3.12	-1.72
Low	-4.20	-4.17	-2.34

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.